News
1d
GlobalData on MSNEU’s Pharma Package falls short of Europe’s goal of global competitivenessProposals for drug exclusivities and feeble measures to combat drug shortages are unlikely to boost innovation, say some ...
Join our API course for an in-depth understanding of active pharmaceutical ingredients in drug manufacturing. Learn the regulatory frameworks of the EU and USA, GMP and GDP practices, and key ...
The announcement of a Life Science Strategy from the European Commission [2 July] includes action to address long-standing ...
Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide and Advanz Pharma Holdco Limited (“Advanz Pharma”), a ...
Altogether, the “pharma package,” issued in the form of a directive and a regulation, represents “the biggest reform to EU’s laws on medicines in over two decades,” according to the Council.
The server encountered an error and could not complete your request. If the problem persists, please contact us using the ...
India’s rising exports to Brazil signal trust in its pharma capabilities: Pharma trade experts: Shardul Nautiyal, Mumbai Thursday, July 3, 2025, 08:00 Hrs [IST] India’s rising ...
Many European pharma companies are taking steps to proactively counter the threats of US tariffs. These measures include challenging their material supply chains, questioning whether the US remains ...
The pharma package The proposals for a regulation and directive that make up the so-called ‘pharma’ package constitute the biggest reform to the EU’s laws on medicines in over two decades. They aim to ...
President Trump’s administration once promised 90 deals in 90 days. When it comes to the European Union, it may be more of a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results